Last reviewed · How we verify

Alginate oligosaccharide

AlgiPharma AS · Phase 2 active Small molecule

Alginate oligosaccharide works by forming a protective barrier on the surface of the mucosa to treat conditions such as gastroesophageal reflux disease (GERD).

Alginate oligosaccharide works by forming a protective barrier on the surface of the mucosa to treat conditions such as gastroesophageal reflux disease (GERD). Used for Gastroesophageal reflux disease (GERD).

At a glance

Generic nameAlginate oligosaccharide
Also known asOligoG
SponsorAlgiPharma AS
Drug classGastrointestinal protectant
ModalitySmall molecule
Therapeutic areaGastrointestinal
PhasePhase 2

Mechanism of action

Alginate oligosaccharide forms a protective barrier on the surface of the mucosa, which helps to neutralize stomach acid and prevent damage to the esophagus. This can provide relief from symptoms of GERD, such as heartburn and regurgitation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results